US stocks traded mixed towards the end of the session, with the Dow Jones up around 30 points on Monday.
The Dow rose 0.10% to 29,327.06, while the NASDAQ fell 0.59% to 10,590.07. The S&P 500 was also down 0.32% to 3,627.92.
Also check this out: Market volatility rises after release of US jobs report
Leading and lagging sectors
Utilities shares rose 0.7% on Monday. lead the sector was power out Pure Cycle Corporation PCYO and Middlesex Water Company MSEX.
In Monday trading, energy stocks fell 1.7%.
top heading
The FDA approved scPharmaceuticals Inc SCPH Furoscix (Furosemide Injection), a proprietary formulation of furosemide administered via an on-body infusor for congestion due to fluid overload in patients with heart failure.
Stock trading UP
- SOBR Safe, Inc. SOBR Shares soared 22% to $3.05 after the company announced a relationship with a distributor with ties to the airline, rail and shipping industries.
- shares of Immunic, Inc. IMUX got a boost, rising 48% to $5.86 after the company announced an oversubscribed $60 million private placement equity funding.
- Applied DNA Sciences, Inc. APDN Shares also rose, jumping 60% to $1.98 after the company announced it had received its largest single order for LinearDNA™, valued at well over the mid-six figures.
Stocks are trading down
- Siyata Mobile Inc. SYTA Shares fell 58% to $0.1272. Siyata Mobile has agreed to sell 15.8 million shares and 1.59 million prefunded warrants to certain institutional investors in a private placement.
- shares of scPharmaceuticals Inc. SCPH fell 24% to $3.78. The FDA has approved scPharmaceuticals’ Furoscix (Furosemide Injection), a proprietary formulation of furosemide to be administered via an on-body infusor for congestion due to fluid overload in patients with heart failure. At the same time, scPharmaceuticals secured a $100 million secured credit facility from Oaktree Capital Management, LP
- Five9, Inc. FIVN was down, falling 22% to $59.67 after the…
